Skip to Content

Zerit

Licence status
Withdrawn: 22/06/2020
Active substances
Stavudine
Dosage Form
Capsule
Licence number
EU/1/96/009/008
Licence holder
Bristol Myers Squibb Pharma EEIG

Licence information

ATC code
J05AF Nucleoside and nucleotide reverse transcriptase inhibitors, J05AF04 stavudine
Route of supply
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued

Stay updated: document advice

The information and documents on this page are subject to frequent updates. We recommend you do not retain saved or printed versions of them. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie